Christopher H. Pruitt

Christopher Pruitt is an associate in the firm's Washington, DC office in the Food & Drug and Government Contracts practice groups.  Mr. Pruitt has experience advising manufacturers of drugs, devices, food, and other products on a range of regulatory issues involving the Food & Drug Administration.  Mr. Pruitt also advises drug manufacturers of legal and regulatory obligations associated with selling products to the Federal Government.

Representative Matters

• Advised pharmaceutical manufacturer on operating procedures and policies regarding promotion of products on internet and new media.
• Reviewed promotional communications of food, device, and drug manufacturers for compliance with FDA promotional rules.
• Advised pharmaceutical manufacturer of obligations to report criminal, civil, and administrative liability under the newly created Federal Awardee Performance and Integrity Information System.
• Drafted federal legislation for non-profit aimed at encouraging research into therapies for pediatric cancer.

Publications and Speeches

• "FAPIIS Final Rule on Public Access to Contractor Information Allows Contractors Limited Opportunity to Dispute Data Release," Covington E-Alert (1/18/2012), Co-Author
• "FDA Issues Draft Guidance on Mobile Medical Applications," Journal of Medical Device Regulation (November 2011), Co-Author
• "FDA Issues Draft Guidance on Mobile Medical Applications," Covington E-Alert (8/4/2011), Co-Author